T Rowe Price Overseas Stock's upcoming portfolio management transition should be smooth, and its attractive approach isn't changing. But the incoming manager's resume isn't as strong as that of the outgoing manager, so the strategy's People rating is lowered to Average from Above Average, while its Process rating remains Above Average.
T. Rowe Price Overseas Stock Advisor PAEIX
- NAV / 1-Day Return 13.40 / +0.22 %
- Total Assets 23.8 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.070%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.89%
- Turnover 7%
USD | NAV as of May 20, 2024 | 1-Day Return as of May 20, 2024, 10:17 PM GMT+0
Morningstar’s Analysis PAEIX
Will PAEIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Siemens AG | 2.48 | 614.0 Mil | Industrials |
Nestle SA | 2.40 | 592.4 Mil | Consumer Defensive |
Taiwan Semiconductor Manufacturing Co Ltd | 2.23 | 551.2 Mil | Technology |
ASML Holding NV | 2.19 | 541.3 Mil | Technology |
Munchener Ruckversicherungs-Gesellschaft AG | 1.68 | 415.9 Mil | Financial Services |
Unilever PLC | 1.63 | 404.0 Mil | Consumer Defensive |
Novo Nordisk A/S Class B | 1.61 | 399.2 Mil | Healthcare |
AXA SA | 1.58 | 390.0 Mil | Financial Services |
Toyota Motor Corp | 1.52 | 376.9 Mil | Consumer Cyclical |
AstraZeneca PLC ADR | 1.51 | 374.5 Mil | Healthcare |